# Digoxin After Acute Heart Failure (DIG-DICA)

Study · id `cardio:ct-nct07321509` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07321509](<https://clinicaltrials.gov/study/NCT07321509>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07321509

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT07321509. Randomized; no masking; primary purpose treatment. Start 2025-12-16 (actual); primary completion 2027-12-16 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT07321509, source copy `cardio:ctgov-nct07321509-2026-06-02`, retrieved 2026-10-26)
- Started: 2025-12-16 (actual) (ClinicalTrials.gov record NCT07321509, source copy `cardio:ctgov-nct07321509-2026-06-02`, retrieved 2026-10-26)
- Primary completion: 2027-12-16 (anticipated) (ClinicalTrials.gov record NCT07321509, source copy `cardio:ctgov-nct07321509-2026-06-02`, retrieved 2026-10-26)
- Completion: 2028-12-16 (anticipated) (ClinicalTrials.gov record NCT07321509, source copy `cardio:ctgov-nct07321509-2026-06-02`, retrieved 2026-10-26)
- Countries: Argentina (ClinicalTrials.gov record NCT07321509, source copy `cardio:ctgov-nct07321509-2026-06-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07321509-2026-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Digoxin After Acute Heart Failure (DIG-DICA)
- Acronym: DIG-DICA
- Condition: Acute Heart Failure (AHF)
- Intervention (Other): Usual Care
- Intervention (Drug): Digoxin
- Lead sponsor: Hospital General de Agudos "Dr. Cosme Argerich"
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)

## Provenance

Content hash: 711c14e4a15e93f46727e6c9110521a3c4a35f40c034aa468969af661558da94
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
